Thick Myocardium: Decoding the Differential with Imaging
Chairperson: Dong Heon Yang (Kyungpook National Univ. / Korea), Kye-Hun Kim (Chonnam National Univ. / Korea)
|
English Session |
| 09:00-09:15 |
Reversible Causes of LV Wall Thickening: Endocrine and Systemic Clues |
29 |
| 09:15-09:30 |
Beyond Common Causes: Infiltrative and Storage Cardiomyopathies |
13 |
| 09:30-09:45 |
HCM, Hypertensive LVH, or Athlete's Heart? How to Tell Them Apart |
186 |
| 09:45-10:00 |
Choosing the Optimal Imaging Modality for Myocardial Thickening |
99 |
| 10:00-10:20 |
Panel Discussion |
|
| Course Objective (ENG) |
|
304 |
| Course Objective (KOR) |
|
305 |
[EACVI-Joint Session] Mitral Regurgitation: New Insights from Imaging for Management
Chairperson: Hae-Ok Jung (Catholic Univ. / Korea),Theo Pezel (University Lariboisiere Hosp. / France)
|
English Session |
| 09:00-09:15 |
Degenerative Mitral Regurgitation: Translational Science Lightening Therapies |
1 |
| 09:15-09:30 |
Mechanistic Insights to Guide Ventricular Functional MR Treatment |
2 |
| 09:30-09:45 |
Atrial FMR : Exploring the Subtypes and Their Clinical Implication |
3 |
| 09:45-10:00 |
TEER in 2025 |
7 |
| 10:00-10:20 |
Panel Discussion |
|
| Course Objective (ENG) |
|
270 |
| Course Objective (KOR) |
|
271 |
[Cross-specialty] Tricuspid Regurgitation: Precision in Complexity – Right Valve, Right Therapy, Right Time
Chairperson: Duk-Hyun Kang (Ulsan Univ. / Korea), Kyung-Hwan Kim (Seoul National Univ. / Korea)
|
English Session |
| 09:00-09:15 |
Managing Tricuspid Regurgitation: Where Are We and Where Are We Going? (Overview) |
70 |
| 09:15-09:30 |
Restoring Rhythm, Relieving Regurgitation: The Impact of Rhythm Control in TR |
193 |
| 09:30-09:45 |
Surgical Interventions in TR: Timing It Right, Doing It Right |
206 |
| 09:45-10:00 |
Transcatheter Therapies on the Rise: T-TEER and the Future of TR Intervention |
216 |
| 10:00-10:20 |
Panel Discussion |
|
| Course Objective (ENG) |
|
294 |
| Course Objective (KOR) |
|
295 |
Genetic Disorders to Consider in Echocardiography: Clinical Scenarios for Genetic Testing
Chairperson: Sang Chol Lee (Sungkyunkwan Univ.), Eui-Young Choi (Yonsei Univ.)
|
|
| 09:00-09:15 |
Thickened Myocardium: HCM, Fabry, Mitochondrial Disorders, Amyloidosis, etc. |
88 |
| 09:15-09:30 |
Ventricular Systolic Dysfunction: DCM, Duchenne/Becker, Mitochondrial Disorders, Danon, etc. |
125 |
| 09:30-09:45 |
Aortopathy and Valvulopathy: Marfan, etc. |
78 |
| 09:45-10:00 |
Pulmonary Hypertension |
133 |
| 10:00-10:20 |
Panel Discussion |
|
| Course Objective (KOR) |
|
286 |
[Surgical Masterclass] Understanding the OR from the Inside
Chairperson: Yong-Jin Kim (Seoul National Univ.), Mi-Jeong Kim (Catholic Univ.)
|
|
| 10:50-11:05 |
The Art of Valve Repair: How We Fix and Why |
118 |
| 11:05-11:20 |
Valve Replacement: The Critical Moment of New Valve Placement |
178 |
| 11:20-11:35 |
Aorta Surgery: Repairing and Replacing the Main Pipe of Circulation |
195 |
| 11:35-11:50 |
Surgery for Congenital Heart Disease in Adults: Still Not Too Late to Correct |
196 |
| 11:50-12:10 |
Panel Discussion |
|
| Course Objective (KOR) |
|
306 |
[ASE-Joint Session] Comprehensive Imaging in HCM
Chairperson: Dae-Gyun Park (Hallym Univ. / Korea), Theodore Abraham (UCSF HCM Center of Excellence / USA)
|
English Session |
| 10:50-11:05 |
HCM Starts at 15 mm… Or Does It?: Revisiting Diagnostic Criteria |
80 |
| 11:05-11:20 |
How I Apply CMR in Real-Life HCM Management: Lessons from Clinical Case Series |
49 |
| 11:20-11:35 |
What to Watch in Echo to Guide Use of Myosin Inhibitors |
205 |
| 11:35-11:50 |
The Journey of HCM Treatment: Where Are We Heading? |
186 |
| 11:50-12:10 |
Panel Discussion |
|
| Course Objective (ENG) |
|
272 |
| Course Objective (KOR) |
|
273 |
[KSHF Joint Session] Imaging the Failing Heart: Echo Across the Spectrum of Heart Failure
Chairperson: Ji Yong Choi (Daegu Catholic Univ.), Seok Min Kang (Yonsei Univ.)
|
|
| 10:50-11:05 |
Echocardiography in Shock: Diagnosing the Mechanism and Guiding Therapy |
31 |
| 11:05-11:20 |
Assessing Volume and Congestion in Heart Failure: What Echo Can (and Can’t) Tell Us |
149 |
| 11:20-11:35 |
Imaging for LVAD Patients: Preoperative Assessment, Post-Implant Monitoring, and Troubleshooting |
24 |
| 11:35-11:50 |
Imaging in Heart Transplant Recipients: Surveillance, Rejection, and Graft Function |
43 |
| 11:50-12:10 |
Panel Discussion |
|
| Course Objective (KOR) |
|
296 |
Young Investigator Award
Chairperson: Joon-Han Shin (Ajou Univ.), Jang-Young Kim (Yonsei Wonju Univ.)
|
|
| 10:50-11:06 |
Prognostic Value of Right Ventricular Pulmonary Artery Coupling to a Clinical Risk Score in Tricuspid Regurgitation |
13 |
| 11:06-11:22 |
The Effect of Mavacamten on Left Atrial Mechanics in Obstructive Hypertrophic Cardiomyopathy |
224 |
| 11:22-11:38 |
Left Atrial Stain Late After Corrective Mitral Valve Surgery in Patients with Mitral Regurgitation: Impact of Surgical Techniques (Replacement vs. Repair) |
223 |
| 11:38-11:54 |
Integrated Myocardial Work Index as a Predictor of Cardiovascular Outcomes in Mixed Aortic Valve Disease. |
222 |
| 11:54-12:10 |
Echocardiographic Drag Effect Index Predicts Response to Mavacamten in Obstructive Hypertrophic Cardiomyopathy |
97 |
[구연발표세션] Case Session (1)
Chairperson: Chi Young Shim (Yonsei Univ.)
|
|
| 10:50-11:02 |
Stroke Patient with Pulmonary Thromboembolism |
239 |
| 11:02-11:14 |
Transcatheter Edge-to-Edge Repair for Severe Mitral Regurgitation in An Octogenarian Woman with Hypertrophic Obstructive Cardiomyopathy: A Case Description |
240 |
| 11:14-11:26 |
Criss-cross Heart in a 2-month-old: A Case Report |
241 |
| 11:26-11:38 |
Multivalvular Calcific Stenosis in a young woman with Tertiary Hyperparathyroidism secondary to Chronic Kidney Disease |
242 |
| 11:38-11:50 |
Incidental Tricuspid Annulus Mass Unveils IgG4-related Coronary Artery Disease |
243 |
| 11:50-12:02 |
Severe Aortic Stenosis and Hypertrophic Cardiomyopathy: Unveiling Dynamic Left Ventricular Outflow Tract Obstruction After Transcatheter Aortic Valve Replacement |
313 |
Lunch & Scientific Session (4)_한국다이이찌산쿄 주식회사 & 대웅제약
Chairperson: Joon-Han Shin (Ajou Univ.), Chi Young Shim (Yonsei Univ.)
|
|
| 12:20-12:50 |
Edoxaban Treatment for High-Risk Elderly Patients_Focused on 3-dose Option |
92 |
| 12:50-13:20 |
Approaches for the Medical Management of Resistant Hypertension: SPARE Trial |
220 |
Lunch & Scientific Session (1)_바이엘코리아 ㈜
Chairperson: Kye-Hun Kim (Chonnam National Univ.), Jae-Hyeong Park (Chungnam National Univ.)
|
|
| 12:20-12:50 |
Evolving Landscape of Riociguat in Pulmonary Hypertension Management: US Experience and Global Perspective |
215 |
| 12:50-13:20 |
Optimizing PAH Management in Korea: Riociguat’s Role in Treatment Algorithm |
164 |
Lunch & Scientific Session (3)_Johnson & Johnson
Chairperson: Hyuck-Jae Chang (Yonsei Univ.)
|
|
| 12:20-12:50 |
Uptravi in PAH: Advanced Initiation Strategies for Long-Term Outcomes |
7 |
| 12:50-13:20 |
PAH Optimal Treatment with Opsynvi – One Formulation , Dual Impact |
133 |
Lunch & Scientific Session (2)_(유) 한국비엠에스제약 & 한국화이자제약 ㈜
Chairperson: Hyung-Kwan Kim (Seoul National Univ.)
|
|
| 12:20-12:50 |
Advancing Treatment Paradigms in Obstructive HCM |
109 |
| 12:50-13:20 |
Value Added Solution for High-Risk Patients with Afib |
11 |
Echocardiography in Consultation: What to Focus On
Chairperson: Kwon-Sam Kim (Kyung Hee Univ.), Seung Woo Park (Sungkyunkwan Univ.)
|
|
| 13:20-13:35 |
Consultation from Hepatology: Severe Liver Disease or Liver Transplant Candidates |
14 |
| 13:35-13:50 |
Consultation from Nephrology: Chronic Kidney Disease or Kidney Transplant Candidates |
100 |
| 13:50-14:05 |
Consultation from Pulmonology: Patients in the ICU |
37 |
| 14:05-14:20 |
Consultation from Rheumatology: Patients with Autoimmune Disease |
166 |
| 14:20-14:40 |
Panel Discussion |
|
| Course Objective (KOR) |
|
307 |
All About Cardiac Amyloid: Diagnosis, Drugs, and Daily Practice
Chairperson: Woo-Shik Kim (Kyung Hee Univ. / Korea), Kyung-Soon Hong (Hallym Univ. / Korea)
|
English Session |
| 13:20-13:35 |
Diagnosing Cardiac Amyloidosis Today: Essential Tools and Pitfalls |
24 |
| 13:35-13:50 |
How and Why We Use Nuclear Imaging in Cardiac Amyloidosis |
150 |
| 13:50-14:05 |
AL Amyloidosis: What Cardiologists Must Know |
202 |
| 14:05-14:20 |
How Transthyretin Stabilizers Change the Game: A Case-Based Approach |
117 |
| 14:20-14:40 |
Panel Discussion |
|
| Course Objective (ENG) |
|
275 |
| Course Objective (KOR) |
|
276 |
Debate [Pericardial Effusion] Pericardial Effusion, PCC or Not ?
Chairperson: Tae-Ho Park (Donga Univ.), Seongwoo Han (Hallym Univ.)
|
|
| 13:20-13:35 |
Voting & Overview |
160 |
| 13:35-13:50 |
Pericardiocentesis Need to Be Considered If Possible for the Diagnosis of Pericardial Effusion, Regardless of Hemodynamic Status |
103 |
| 13:50-14:05 |
Pericardiocentesis Should Be Considered Only in Cases of Hemodynamic Compromise |
83 |
| 14:05-14:20 |
Crossfire & Expert Panel Discussion |
|
| 14:20-14:40 |
Voting & Wrap Up |
|
| Course Objective (KOR) |
|
297 |
Pulmonary Hypertension 2025: Imaging, Therapy, and Multidisciplinary Care
Chairperson: Hae-Ok Jung (Catholic Univ. / Korea), Wook-Jin Chung (Gachon Univ. / Korea)
|
English Session |
| 13:20-13:35 |
Echo in PH: Updated Standard Protocol for PH Diagnosis and Treatment Guiding |
133 |
| 13:35-14:05 |
Recent Updates in Medical Treatment of PH: Are We Entering A Remission Era in PAH? |
215 |
| 14:05-14:20 |
Multidisciplinary Team Approach in PH: What Makes A Real Difference in Outcomes |
7 |
| 14:20-14:40 |
Panel Discussion |
|
| Course Objective (ENG) |
|
287 |
| Course Objective (KOR) |
|
288 |
[EACVI HIT Joint Session] Building Cardiovascular Imaging Registries
Chairperson: Theo Pezel (University Lariboisiere Hosp. / Paris), Inki Moon (Soonchunhyang Univ. / Korea)
|
English Session |
| 13:20-13:35 |
Nationwide Valve Survey in Korea: Current Landscape and Future Directions |
50 |
| 13:35-13:50 |
20 Years of Peri-Partum Cardiomyopathy in Korea: Insights from A Nationwide Multicenter Registry |
58 |
| 13:50-14:05 |
AI in Aortic Stenosis: Nationwide Imaging Data and Clinical Value |
66 |
| 14:05-14:20 |
Global Collaboration in Echocardiographic Registries: MMVD & INFLAME |
1 |
| 14:20-14:40 |
Panel Discussion |
|
In-Depth HVD Echo Tutorial Session with Leading Experts
Chairperson: Speaker, Sung-Ji Park(Sungkyunkwan Univ.)
|
|
Echo Frontiers: Research Adventures with Echocardiography 심초음파와 함께한 연구 모험: 실전 경험과 노하우 공유
Chairperson: Jong-Won Ha (Yonsei Univ.), Seung-Pyo Lee (Seoul National Univ.)
|
|
| 15:10-15:25 |
Speckle Detectives: Building and Mining Your 2D-Speckle Tracking Echo Cohort |
176 |
| 15:25-15:40 |
The Invisible Culprit: Catching Microvascular Angina Red-Handed with Coronary Flow Reserve |
34 |
| 15:40-15:55 |
Heart Meets Chemo: Navigating the Cardio-Oncology Research Rollercoaster |
72 |
| 15:55-16:10 |
Cluster Magic: Patient Phenotyping Through Machine Learning - Tips from the Trenches |
14 |
| 16:10-16:30 |
Panel Discussion |
|
| Course Objective (KOR) |
|
308 |
Patients, Society, and US: Beyond Imaging, Listening to Every Heart
Chairperson: Won Ho Kim (Jeonbuk National Univ.), Hae-Ok Jung (Catholic Univ.)
|
|
| 15:10-15:40 |
세상과 대화하다: 의사와 사회의 소통 |
194 |
| 15:40-16:10 |
마음의 울림을 만드는 말하기 — 주위 사람들과의 소통 |
190 |
| 16:10-16:30 |
Panel Discussion |
|
| Course Objective (KOR) |
|
277 |
[Cross-specialty] Severe Bicuspid Aortic Valve Stenosis in Non-High Risk Surgical Patients
Chairperson: Kiyuk Chang (Catholic Univ.), Shin-Jae Kim (Ulsan Univ.)
|
|
| 15:10-15:25 |
Bicuspid Aortic Valve: What It Is, Why It Matters, and What We Need to Know |
90 |
| 15:25-15:40 |
Intervention-Focused CT Imaging in Bicuspid Aortic Valve: What We Must Consider |
15 |
| 15:40-15:55 |
TAVI in Bicuspid Aortic Valve Stenosis: Techniques, Evidence, and Unmet Needs |
96 |
| 15:55-16:10 |
When Surgery Is Still the Right Answer for Bicuspid Aortic Valve Patients |
195 |
| 16:10-16:30 |
Panel Discussion |
|
| Course Objective (KOR) |
|
298 |
[JSE -Joint Session] Strain Imaging Across the Spectrum of Cardiovascular Disease
Chairperson: Geu-Ru Hong (Yonsei Univ. / korea), Hiroyuki Okura (Gifu Univ. / Japan)
|
English Session |
| 15:10-15:25 |
Aging and Strain: How Myocardial Function Changes Over Time |
184 |
| 15:25-15:40 |
Strain Imaging in Valvular Heart Disease: From Assessment to Decision-Making |
25 |
| 15:40-15:55 |
Strain Imaging in Cardio-Oncology: Detecting and Preventing Cardiotoxicity |
181 |
| 15:55-16:10 |
Strain Imaging Across the Spectrum of Cardiovascular Disease |
185 |
| 16:10-16:30 |
Panel Discussion |
|
| Course Objective (ENG) |
|
292 |
| Course Objective (KOR) |
|
291 |
